Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study.
Neurogastroenterol Motil
; 29(6)2017 Jun.
Article
in En
| MEDLINE
| ID: mdl-28205278
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Serotonin Antagonists
/
Benzimidazoles
/
Irritable Bowel Syndrome
/
Diarrhea
Type of study:
Clinical_trials
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Neurogastroenterol Motil
Journal subject:
GASTROENTEROLOGIA
/
NEUROLOGIA
Year:
2017
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom